Navigation Links
GSK Seeks Permission to Market Breast Cancer Pill Tykerb

GlaxoSmithKline PLC has filed for permission with European medicine regulators to begin selling its new breast cancer pill Tykerb//.

This follows a similar move in the US last month, and comes slightly earlier than some commentators were expecting.

The drug is foreseen to be one of GSK's most promising pipeline drugs as well as a potential blockbuster. According to analysts at Nomura Code the sales of the drug could cross 2 bln used by 2010.

GSK, Europe's biggest pharmaceutical company has given an application for a license to market the drug as a treatment for advanced breast cancer wherein cancer has spread to other parts of the body. It is to be taken in combination with the chemotherapy agent Xeloda, made by Roche Holdings AG.

Possible candidates for the treatment are women who failed to respond to Roche's and Genentech Inc's drug Herceptin.

While Tykerb is taken daily in a pill form, Herceptin is given as injections every month.

Clinical trials showed a longer time to disease progression among women taking Tykerb, almost double that seen among those receiving e chemotherapy agent alone.

Positive results caused an early end to the trial.

According to GSK over 360,000 new cases of breast cancer are diagnosed every year in Europe, and around half of those women will go on to develop advanced, or metastatic disease.
NLA
'"/>




Page: 1

Related medicine news :

1. Gujarat Seeks To Scale Down Infant Mortality Rate
2. Europe Seeks Indian Expertise
3. Book Seeks To Rehabilitate Soldiers
4. Government Seeks To Wipe Out Prostitution
5. Multiple Sclerosis Patient Seeks Help of Stem Cells
6. AIIMS Doctors Seeks Ramadoss Intervention For Venugopal’s Remova
7. Human Chain Seeks AIIMS Status For Tiruchi Medical College
8. Harney Seeks Approval for New Medical Practitioners Bill
9. Drug Company Seeks Approval for Human Testing of Vaccine against H5N1 Virus
10. BJP Seeks Tougher Laws Against Pre-Natal Sex Tests
11. Valiathan Committee Seeks Documents from AIIMS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Doctor C ... it attended the January ECRM trade show to continue the marketing and distribution of ... C supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out of ... it attended the January ECRM trade show in Hilton Head, SC. , International ... determined to create a line of products that would elevate her fitness regime. At ...
(Date:1/20/2017)... ... ... “Mary Magdalene: Grace is Greater than Sin”: a unique and memorable piece of ... Magdalene: Grace is Greater than Sin” is the creation of published author, Brenda Roberts, ... who had little knowledge of the female characters portrayed in the Holy Bible. ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... ... “The Land of More and More”: a brilliant story for children ... the simple and achievable answer. “The Land of More and More” is the creation ... in Angola, Indiana where he works with the children’s ministry department. , Michael ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
Breaking Medicine Technology: